Price $89.48 |
Market Cap
121.46B
|
Sector Health Care |
Div. Growth
8.70%
|
|
P/E
18.6
|
P/B
-
|
P/S
4.03
|
Dividend %
4.80%
|
|
P/CF
29.9
|
P/FCF
22.2
|
Op. Cash Flow
10.5M
|
FCF
3.5
|
|
Op. Margin
32.60%
|
Net Margin
20.50%
|
ROE
212.40%
|
ROI
17.80%
|
|
ROA
9.40%
|
EPS Growth
-2.60%
|
Current Ratio
1.3
|
Debt/Equity
607.30%
|
| Company | Price | P/E | Div. Yield | Market Cap ($Mil) | Rating |
|---|---|---|---|---|---|
| Oncolytics Biotech, Inc. (USA) (ONCY) | $2.53 | - | - | 49.2M | Strong Buy |
| RTI Surgical Inc (RTIX) | $4.29 | - | - | 289.6M | Strong Buy |
| Endo International PLC (ENDP) | $12.46 | - | - | 3.82B | Strong Buy |
| Sangamo Therapeutics Inc (SGMO) | $10.74 | - | - | 1.42B | Strong Buy |
| SANUWAVE Health, Inc. (SNWV) | $0.22 | - | - | 22.8M | Strong Buy |
Please note that all recommendations are based on our model's results and do not represent our personal opinion. The stock Rating process is purely mechanical.
All analysis relies on publicly available financial information. Learn More
